دوره 15، شماره 10 - ( دی 1400 )                   جلد 15 شماره 10 صفحات 673-660 | برگشت به فهرست نسخه ها

XML English Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mashhadi M, Sahebozamani M, Daneshjoo A, Adeli S H, Venarji N. Persistent Symptoms in Recovered Patient From Covid-19 and the Importance of Post-acute Rehabilitation: A Systematic Review. Qom Univ Med Sci J 2022; 15 (10) :660-673
URL: http://journal.muq.ac.ir/article-1-3144-fa.html
مشهدی محمد، صاحب الزمانی منصور، دانشجو عبدالحمید، عادلی سید حسن، ونارجی ناهید. علائم ماندگار در بهبودیافتگان کووید-19و اهمیت توانبخشی پسا حاد: مطالعه مروری نظام‌مند. مجله دانشگاه علوم پزشکی قم. 1400; 15 (10) :660-673

URL: http://journal.muq.ac.ir/article-1-3144-fa.html

علائم ماندگار در بهبودیافتگان کووید-19و اهمیت توانبخشی پسا حاد: مطالعه مروری نظام‌مند
محمد مشهدی* 1، منصور صاحب الزمانی2 ، عبدالحمید دانشجو2 ، سید حسن عادلی3 ، ناهید ونارجی4
1- گروه آسیب شناسی ورزشی و تمرینات اصلاحی، دانشکده علوم ورزشی، دانشگاه شهید باهنر کرمان، کرمان، ایران ، md.mashhadi@gmail.com
2- گروه آسیب شناسی ورزشی و تمرینات اصلاحی، دانشکده علوم ورزشی، دانشگاه شهید باهنر کرمان، کرمان، ایران
3- گروه داخلی، دانشکده پزشکی، دانشگاه علوم پزشکی قم، قم، ایران
4- گروه پزشکی ورزشی، مجتمع آموزشی درمانی حضرت رسول اکرم، دانشکده پزشکی، دانشگاه علوم پزشکی ایران، تهران، ایران
چکیده:   (2439 مشاهده)
زمینه و هدف: سندرم حاد تنفسی کووید-19 در سراسر جهان گسترش یافته و عوارض و علائم ماندگار مختلفی، از‌جمله اختلالات مختلف جسمانی و روانی در بیماران ترخیص‌شده و بهبودیافته مشاهده شده است. هدف از مطالعه مروری حاضر، بررسی علائم ماندگار در بهبودیافتگان کووید-19 و اهمیت توانبخشی در مرحله پسا حاد بود.
روش بررسی: در این مطالعه مروری نظام‌مند، مقالات مرتبط از پایگاه‌های اطلاعاتی شامل مدلاین، پابمد، گوگل اسکالر، ساینس‌دایرکت، مرکز اطلاعات علمی جهاد دانشگاهی، کتابخانه ملی دیجیتال پزشکی ایران، وب‌آو‌ساینس، اسکوپوس، اشپرینگر از سال 2019 تا اوت سال 2021 بررسی شد. همچنین در فرایند جست‌وجو مقالات از کلیدواژه‌های کووید-19 (و مشابه آن) بهبودیافتگان، بازماندگان، ترخیص‌شدگان، علائم ماندگار، پیامدها و پسا حاد استفاده شد.
یافته‌ها: در جست‌وجوی مقالات در پایگاه‌های داده 10227 مقاله شناسایی شد. پس از حذف مقالات تکراری، مقالات به زبان‌های غیرفارسی و انگلیسی، مقالات غیرپژوهشی و غیرمرتبط با موضوع، تعداد 61 مقاله به ‌دست آمد که به بررسی علائم ماندگار بیماران ترخیص‌شده و بهبودیافته پرداخته بودند. بیشترین علائم شامل تنگی نفس، خستگی و ضعف اکتسابی، مشکلات روان‌شناختی و کاهش کیفیت زندگی بود.
نتیجه‌گیری: یافته‌ها نشان داد با توجه به علائم ماندگار و شرایط بالینی ناشی از بیماری کووید-19، توانبخشی حرکتی و ریوی برای بهبودیافتگان ضروری است. این برنامه‌ها باید در بخش‌های تخصصی یا از طریق توانبخشی خانگی با هدف بازیابی مهارت‌های حرکتی و بهبود وضعیت روانی ادامه یابد.
واژه‌های کلیدی: کووید-19، بهبودیافتگان،توانبخشی، علائم ماندگار، علائم پسا حاد کووید-19
متن کامل [PDF 5994 kb]   (620 دریافت) |   |   متن کامل (HTML)  (1246 مشاهده)  
نوع مطالعه: مقاله مروری | موضوع مقاله: فیزیولوژی ورزشی
دریافت: 1400/2/29 | پذیرش: 1400/5/23 | انتشار: 1400/10/10
فهرست منابع
1. Ghanjal A, Motaqi M. [Respiratory Physiotherapy in COVID-19 based on Available Evidence-Narrative Review (Persian)]. J Marine Med. 2020; 2(1):26-32. https://www.sid.ir/fa/journal/ViewPaper.aspx?id=550332.
2. Omidi A, Shatizadeh Malekshahi S, Veisi P. [Extra pulmonary manifestations of COVID-19: A narrative review (Persian)]. J Arak Uni Med Sci. 2020; 2(3). http://jams.arakmu.ac.ir/browse.php?a_id=6318&slc_lang=fa&sid=1&ftxt=1&html=1
3. Al-Jahdhami I, Al-Naamani K, Al-Mawali A. The post-acute COVID-19 syndrome (long COVID). Oman Med J. 2021; 36(1):e220. [DOI:10.5001/omj.2021.91] [PMID] [PMCID] [DOI:10.5001/omj.2021.91]
4. Grabowski DC, Joynt Maddox KE. Postacute care preparedness for COVID-19: Thinking ahead. JAMA. 2020; 323(20):2007-2008. [DOI:10.1001/jama.2020.4686] [PMID] [DOI:10.1001/jama.2020.4686]
5. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020; 323(16):1612-4. [DOI:10.1001/jama.2020.4326] [PMID] [PMCID] [DOI:10.1001/jama.2020.4326]
6. Munblit D, Nekliudov NA, Bugaeva P, Blyuss O, Kislova M, Listovskaya E, et al. Stop COVID Cohort: An observational study of 3480 patients admitted to the sechenov university hospital network in Moscow for suspected coronavirus disease 2019 (COVID-19) infection. Clin Infect Dis. 2021; 73(1):1-11. [DOI:10.1093/cid/ciaa1535] [PMID] [PMCID] [DOI:10.1093/cid/ciaa1535]
7. Goërtz YM, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FV, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020; 6:e0054. [DOI:10.1183/23120541.00542-2020] [PMID] [PMCID] [DOI:10.1183/23120541.00542-2020]
8. Debeaumont D, Boujibar F, Ferrand-Devouge E, Artaud-Macari E, Tamion F, Gravier FE, et al. Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalization: A pilot study. Phys Ther. 2021; 101(6):pzab099. [DOI:10.1093/ptj/pzab099] [PMID] [PMCID] [DOI:10.1093/ptj/pzab099]
9. Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA. 2021; 4:e2036142. [DOI:10.1001/jamanetworkopen.2020.36142] [PMID] [PMCID] [DOI:10.1001/jamanetworkopen.2020.36142]
10. Hall J, Myall K, Lam JL, Mason T, Mukherjee B, West A, et al. Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 2021; 76(4):408-11. [DOI:10.1136/thoraxjnl-2020-215861] [PMID] [PMCID] [DOI:10.1136/thoraxjnl-2020-215861]
11. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EclinicalMedicine. 2020; 25:100463. [DOI:10.1016/j.eclinm.2020.100463] [PMID] [PMCID] [DOI:10.1016/j.eclinm.2020.100463]
12. Islam N, Lewington S, Kharbanda RK, Davies J, Várnai KA, Lacey B. Sixty-day consequences of COVID-19 in patients discharged from hospital: An electronic health records study. Eur J Public Health. 2021; 31:280-2. [DOI:10.1093/eurpub/ckab009] [PMID] [PMCID] [DOI:10.1093/eurpub/ckab009]
13. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021; 93(2):1013-1022. [DOI:10.1002/jmv.26368] [PMID] [DOI:10.1002/jmv.26368]
14. Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is long-covid and how should we manage it? Lung. 2021; 199(2):113-9. [DOI:10.1007/s00408-021-00423-z] [PMID] [PMCID] [DOI:10.1007/s00408-021-00423-z]
15. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021; 397(10270):220-32. [DOI:10.1016/S0140-6736(20)32656-8] [DOI:10.1016/S0140-6736(20)32656-8]
16. Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020; 15(12):e0243882. [DOI:10.1371/journal.pone.0243882] [PMID] [PMCID] [DOI:10.1371/journal.pone.0243882]
17. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects:a population-based cohort study. Thorax. 2021; 76(4):405-7. [DOI:10.1136/thoraxjnl-2020-216377] [PMID] [PMCID] [DOI:10.1136/thoraxjnl-2020-216377]
18. Paneroni M, Simonelli C, Saleri M, Bertacchini L, Venturelli M, Troosters T, et al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am J Phys Med Rehabil. 2021; 100(2):105-9. [DOI:10.1097/PHM.0000000000001641] [PMID] [DOI:10.1097/PHM.0000000000001641]
19. VanAerde N, Van den Berghe G, Wilmer A, Gosselink R, Hermans G. COVID-19 consortium:Intensive care unit acquired muscle weakness in COVID-19 patients. Intensive Care Med. 2020; 46(11):2083-5. [DOI:10.1007/s00134-020-06244-7] [PMID] [PMCID] [DOI:10.1007/s00134-020-06244-7]
20. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-90. [DOI:10.1001/jamaneurol.2020.1127] [PMID] [PMCID] [DOI:10.1001/jamaneurol.2020.1127]
21. Bagnato S, Boccagni C, Marino G, Prestandrea C, D'Agostino T, Rubino F. Critical illness myopathy after COVID-19. Int J Infect Dis. 2020; 99:276-278. [DOI:10.1016/j.ijid.2020.07.072] [PMID] [PMCID] [DOI:10.1016/j.ijid.2020.07.072]
22. Taboada M, Moreno E, Carinena A, Rey T, Pita-Romero R, Leal S, et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. 2021; 126(3):e110-e113. [DOI:10.1016/j.bja.2020.12.007] [PMID] [PMCID] [DOI:10.1016/j.bja.2020.12.007]
23. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020; 81(6):e4-e6. [DOI:10.1016/j.jinf.2020.08.029] [PMID] [PMCID] [DOI:10.1016/j.jinf.2020.08.029]
24. Todt BC, Szlejf C, Duim E, Linhares AOM, Kogiso D, Varela G, et al. Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge. Respir Med. 2021; 184:106453. [DOI:10.1016/j.rmed.2021.106453] [PMID] [PMCID] [DOI:10.1016/j.rmed.2021.106453]
25. Arnold DT , Hamilton FW , Milne A. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021; 76:400-3. [DOI:10.1101/2020.08.12.20173526] [DOI:10.1101/2020.08.12.20173526]
26. Zampogna E, Migliori GB, Centis R, Cherubino F, Facchetti C, Feci D, et al. Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients. Pulmonology. 2021; 27(5):452-5. [DOI:10.1016/j.pulmoe.2020.12.008] [PMID] [PMCID] [DOI:10.1016/j.pulmoe.2020.12.008]
27. Denay KL, Breslow RG, Turner MN, Nieman DC, Roberts WO, Best TM. ACSM Call to Action Statement: COVID-19 Considerations for Sports and Physical Activity. Curr Sports Med Rep. 2020; 19(8):326-8. [DOI:10.1249/JSR.0000000000000739] [PMID] [DOI:10.1249/JSR.0000000000000739]
28. Wang D, Li J, Zhu F, Hong Q, Zhang M, Gao M, et al. Protocol for a systematic review and meta-analysis of respiratory rehabilitation following intensive care unit discharge for COVID-19 survivors. BMJ Open. 2020; 10(12):e041184. [DOI:10.1136/bmjopen-2020-041184] [PMID] [PMCID] [DOI:10.1136/bmjopen-2020-041184]
29. Pincherle A, Jöhr J, Pancini L, Leocani L, Dalla Vecchia L, Ryvlin P, et al. Intensive Care Admission and Early Neuro-Rehabilitation: Lessons for COVID-19? Front Neurol. 2020; 11:880. [DOI:10.3389/fneur.2020.00880] [PMID] [PMCID] [DOI:10.3389/fneur.2020.00880]
30. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020; 323(16):1574-81. [DOI:10.1001/jama.2020.5394] [PMID] [PMCID] [DOI:10.1001/jama.2020.5394]
31. Soltaninejad M, arab M, abaszadeh A, borhani F, karzari Z. [The effect of using self-help rehabilitation program on the life quality of the patients discharged from Intensive Care Units (Persian)]. Iran J Critic Care Nurs. 2014; 7(1):1-6. https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=362114
32. Zheng YY, Ma YT, Zhang JY. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17(5):259-60. [DOI:10.1038/s41569-020-0360-5] [PMID] [PMCID] [DOI:10.1038/s41569-020-0360-5]
33. Hammami A, Harrabi B, Mohr M, Krustrup P. Physical activity and coronavirus disease 2019 (COVID-19): Specific recommendations for home-based physical training. Manag Sport Leis. 2020; 1-6. [DOI:10.1080/23750472.2020.1757494] [DOI:10.1080/23750472.2020.1757494]
34. Amini M, Gholami M, Aabed Natanzi H, Shakeri N, Haddad H. Effect of diaphragmatic respiratory training on some pulmonary indexes in older people with chronic obstructive pulmonary disease. Salmand: Iran J Ageing. 2019; 14(3):332-41. https://salmandj.uswr.ac.ir/article-1-1409-en.html
35. Chen R, Gao Y, Chen M, Jian W, Lei C, Zheng J, et al. Impaired pulmonary function in discharged patients with COVID-19: More work ahead. Eur Respir J. 2020; 56(1):2002194. [DOI:10.1183/13993003.02194-2020] [PMID] [PMCID] [DOI:10.1183/13993003.02194-2020]
36. Xiaoneng Mo, Wenhua Jian, Zhuquan Su, Mu Chen, Hui Peng, Ping Peng, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharg. Eur Respir J. 2020; 55(6):2001217. [DOI:10.1183/13993003.01217-2020] [PMID] [PMCID] [DOI:10.1183/13993003.01217-2020]
37. Jiménez-Pavón D, Carbonell-Baeza A, Lavie CJ. Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people. Prog Cardiovasc Dis. 2020; 63(3):386-8. [DOI:10.1016/j.pcad.2020.03.009] [PMID] [PMCID] [DOI:10.1016/j.pcad.2020.03.009]
38. Narici M, Vito G, Franchi M, Paoli A, Moro T, Marcolin G, et al. Impact of sedentarism due to the COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: Physiological and pathophysiological implications and recommendations for physical and nutritional countermeasures. Eur J Sport Sci. 2021; 21(4):614-35. [DOI:10.1080/17461391.2020.1761076] [PMID] [DOI:10.1080/17461391.2020.1761076]
39. Jung NJ, Na SS, Kim SK, Hwangbo G. The effect of the inspiratory muscle training on functional ability in stroke patients. J Phys Ther Sci. 2017; 29(11):1954-56. [DOI:10.1589/jpts.29.1954] [PMID] [PMCID] [DOI:10.1589/jpts.29.1954]
40. Zhao HM, Xie YX, Wang C; Chinese Association of Rehabilitation Medicine; Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine; Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl). 2020; 133(13):1595-602. [DOI:10.1097/CM9.0000000000000848] [PMID] [PMCID] [DOI:10.1097/CM9.0000000000000848]
41. Shirvani H, Rostamkhani F. [Exercise Considerations during Coronavirus Disease 2019 (COVID-19) Outbreak:A Narrative Review (Persian)]. J Mil Med. 2020; 22(2):161-8. https://www.researchgate.net/publication/340634089_Exercise_Disease_COVID-19_Outbreak_A_Narrative_Review
42. Polastri M, Nava S, Clini E, Vitacca M, Gosselink R. COVID-19 and pulmonary rehabilitation: Preparing for phase three. Eur Respir J. 2020; 55(6):2001822. [DOI:10.1183/13993003.01822-2020] [PMID] [PMCID] [DOI:10.1183/13993003.01822-2020]
43. Woods JA, Hutchinson NT, Powers SK, Roberts WO, Gomez-Cabrera MC, Radak Z, et al. The COVID-19 pandemic and physical activity. Sports Med Health Sci. 2020; 2(2):55-64. [DOI:10.1016/j.smhs.2020.05.006] [PMID] [PMCID] [DOI:10.1016/j.smhs.2020.05.006]
44. Dubé BP, Dres M. Diaphragm dysfunction: Diagnostic approaches and management strategies. J Clin Med. 2016; 5(12):113. [DOI:10.3390/jcm5120113] [PMID] [PMCID] [DOI:10.3390/jcm5120113]
45. Hodges PW, Gandevia SC. Changes in intra-abdominal pressure during postural and respiratory activation of the human diaphragm. J Appl Physiol. 2000; 89(3):967-76. [DOI:10.1152/jappl.2000.89.3.967] [PMID] [DOI:10.1152/jappl.2000.89.3.967]
46. Chuatrakoon B, Ngai SPC, Sungkarat S, Uthaikhup S. Balance impairment and effectiveness of exercise intervention in chronic obstructive pulmonary disease: A systematic review. Arch Phys Med Rehabil. 2020; 101(9):1590-602. [DOI:10.1016/j.apmr.2020.01.016] [PMID] [DOI:10.1016/j.apmr.2020.01.016]
47. Porto E, Mattos de Castro AA, Schmidt V, Rabelo H, Kumpel C, Nascimento O, et al. Postural control in chronic obstructive pulmonary disease: A systematic review. Int J Chron Obstruct Pulmon Dis. 2015; 10(1):1233-9. [DOI:10.2147/COPD.S63955] [PMID] [PMCID] [DOI:10.2147/COPD.S63955]
48. Mazza MG, De Lorenzo R, Conte C, et al. COVID-19 BioB Outpatient Clinic Study group. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020; 89:594-600. [DOI:10.1016/j.bbi.2020.07.037] [PMID] [PMCID] [DOI:10.1016/j.bbi.2020.07.037]
49. Limoee K, Molavynejad S, Asadizaker M, Heidari A, Maraghi E. Effect of home-based cardiac rehabilitation on health related quality of life of patients following CABG surgery: A randomized clinical trial. Hayat. 2019; 25 (2):124-37. https://www.sid.ir/En/Journal/ViewPaper.aspx?ID=773742
50. Ghanjal A, Motaqi M. [Functional dimensions and rehabilitation status in COVID-19 patients: Narrative review (Persian)]. J Mil Med. 2020; 22(6):641-7. https://www.sid.ir/fa/Journal/ViewPaper.aspx?ID=534744
51. Sheehy LM. Considerations for postacute rehabilitation for survivors of COVID-19. JMIR Public Health Surveill. 2020; 6(2):e19462. [DOI:10.2196/19462] [PMID] [PMCID] [DOI:10.2196/19462]
52. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324(6):603-5. [DOI:10.1001/jama.2020.12603] [PMID] [PMCID] [DOI:10.1001/jama.2020.12603]
53. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11):1265-73. [DOI:10.1001/jamacardio.2020.3557] [PMID] [PMCID] [DOI:10.1001/jamacardio.2020.3557]
54. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. 'Long-COVID': A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021; 76(4):396-8. [DOI:10.1136/thoraxjnl-2020-215818] [PMID] [PMCID] [DOI:10.1136/thoraxjnl-2020-215818]
55. Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: A prospective cohort study. Eur Respir J 2020; 56(5):2003276. [DOI:10.1183/13993003.03276-2020] [PMID] [PMCID] [DOI:10.1183/13993003.03276-2020]
56. Rosales-Castillo A, de Los Ríos CG, García JD. Persistent symptoms after acute COVID-19 infection: Importance of follow-up. Med Clin (Barc). 2021; 156(1):35-6. [DOI:10.1016/j.medcle.2020.08.003] [PMID] [PMCID] [DOI:10.1016/j.medcle.2020.08.003]
57. Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O, et al. 'Long COVID': Persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect Dis. 2021; 21(1):304. [DOI:10.1186/s12879-020-05716-x] [PMID] [PMCID] [DOI:10.1186/s12879-020-05716-x]
58. Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021; 27(2):258-63. [DOI:10.1016/j.cmi.2020.09.052] [PMID] [PMCID] [DOI:10.1016/j.cmi.2020.09.052]
59. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin Microbiol Infect. 2021; 27(1):89-95. [DOI:10.1016/j.cmi.2020.09.023] [PMID] [PMCID] [DOI:10.1016/j.cmi.2020.09.023]
60. Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, et al. Rapid implementation of a cohort for the study of post acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv 2021; 03(11):21252311. [DOI:10.1101/2021.03.11.21252311] [PMID] [PMCID] [DOI:10.1101/2021.03.11.21252311]
61. Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: A cautionary tale during a global pandemic. Clin Infect Dis. 2021; 73(3):e826-e9. [DOI:10.1093/cid/ciab103] [PMID] [PMCID] [DOI:10.1093/cid/ciab103]
62. Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 infection. JAMA. 2021; 4(2):e210830. [DOI:10.1001/jamanetworkopen.2021.0830] [PMID] [PMCID] [DOI:10.1001/jamanetworkopen.2021.0830]
63. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of Long-COVID: Analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. 2020; 10(19):20214494. [DOI:10.1101/2020.10.19.20214494] [DOI:10.1101/2020.10.19.20214494]
64. Iqbal A, Iqbal K, Ali SA, Azim D, Farid E, Baig MD, et al. The COVID-19 sequelae: A cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021; 13(2):e13080. [DOI:10.7759/cureus.13080] [DOI:10.7759/cureus.13080]
65. Cirulli ET, Barrett KMS, Riffle S, Bolze A, Neveux I, Dabe S, et al. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020; 10(07):20208702. [DOI:10.1101/2020.10.07.20208702] [DOI:10.1101/2020.10.07.20208702]
66. Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, Á Steig B, Gaini S, et al. Long COVID in the Faroe Islands: A longitudinal study among non-hospitalized patients. Clin Infect Dis. 2021; 73(11):e4058-e63. [DOI:10.1093/cid/ciaa1792] [PMID] [PMCID] [DOI:10.1093/cid/ciaa1792]
67. Galván-Tejada CE, Herrera-García CF, Godina-González S, Villa-grana-Bañuelos KE, Amaro JDL, Herrera-García K, et al. Persistence of COVID-19 symptoms after recovery in mexican population. Int J Environ Res Public Health. 2020; 17(24):9367. [DOI:10.3390/ijerph17249367] [PMID] [PMCID] [DOI:10.3390/ijerph17249367]
68. Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, et al. COVID-19 symptoms: Longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2020; 174(5):723-5. [DOI:10.7326/M20-5926] [PMID] [PMCID] [DOI:10.7326/M20-5926]
69. Writing Committee for the COMEBAC Study Group, Morin L, Savale L, Pham T, Colle R, Figueiredo S, et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021; 325(15):1525-34. [DOI:10.1001/jama.2021.3331] [PMID] [PMCID] [DOI:10.1001/jama.2021.3331]
70. Venturelli S, Benatti SV, Casati M, Binda F, Zuglian G, Imeri G, et al. Surviving COVID-19 in Bergamo Province: A post-acute outpatient re-evaluation. Epidemiol Infect. 2021; 149:e32. [DOI:10.1017/S0950268821000145] [PMID] [PMCID] [DOI:10.1017/S0950268821000145]
71. Suárez-Robles M, Iguaran-Bermúdez MDR, García-Klepizg JL, Lorenzo-Villalba N, Méndez-Bailón M. Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call check list. Pan Afr Med J. 2020; 37:289. [DOI:10.11604/pamj.2020.37.289.27110] [PMID] [PMCID] [DOI:10.11604/pamj.2020.37.289.27110]
72. Zhou M, Cai J, Sun W, Jing W, Wang Y, Gamber M, Fan L, He G. Do post-COVID-19 symptoms exist? A longitudinal study of COVID-19 sequelae in Wenzhou, China. Ann Med Psychol (Paris). 2021; 179(9):818-21. [DOI:10.1016/j.amp.2021.03.003] [PMID] [PMCID] [DOI:10.1016/j.amp.2021.03.003]
73. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021; 75(3):e13746. [DOI:10.1111/ijcp.13746] [PMCID] [DOI:10.1111/ijcp.13746]
74. Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, et al. Clinical features and outcomes of discharged coronavirus disease 2019 patients: A prospective cohort study. QJM 2020;113(9):657-65. [DOI:10.1093/qjmed/hcaa178] [PMID] [PMCID] [DOI:10.1093/qjmed/hcaa178]
75. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020; 15(11):e0240784. [DOI:10.1371/journal.pone.0240784] [PMID] [PMCID] [DOI:10.1371/journal.pone.0240784]
76. Weerahandi H, Hochman KA, Simon E, Blaum C, Chodosh J, Duan E, et al. Post-discharge health status and symptoms in patients with severe COVID-19. medRxiv. 2020; 14(8):20172742. [DOI:10.1101/2020.08.11.20172742] [DOI:10.1101/2020.08.11.20172742]
77. Sabina S, Thomas S, Alex P, Gerlig W, Anna L, Magdalena A, et al. Persisting pulmonary impairment following severe SARS-CoV-2 infection, preliminary results from the CovILD study. Eur Respir J. 2020; 56(Suppl 64):4143. [DOI:10.1183/13993003.congress-2020.4143] [DOI:10.1183/13993003.congress-2020.4143]
78. Tosato M, Carfì A, Martis I, Pais C, Ciciarello F, Rota E, et al. COVID-19 post-acute care team. Prevalence and predictors of persistence of covid-19 symptoms in older adults: A single-center study. J Am Med Dir Assoc. 2021; 22(9):1840-4. [DOI:10.1016/j.jamda.2021.07.003] [PMID] [PMCID] [DOI:10.1016/j.jamda.2021.07.003]
79. Aranda J, Oriol I, Martín M, Feria L, Vázquez N, Rhyman N, et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J Infect. 2021; 83(5):581-8. [DOI:10.1016/j.jinf.2021.08.018] [PMID] [PMCID] [DOI:10.1016/j.jinf.2021.08.018]
80. Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021; 27(10):1507-13. [DOI:10.1016/j.cmi.2021.05.033] [PMID] [PMCID] [DOI:10.1016/j.cmi.2021.05.033]
81. Leite VF, Rampim DB, Jorge VC, de Lima MDCC, Cezarino LG, da Rocha CN; Prevent Senior COVID-19 Rehabilitation Study. Persistent symptoms and disability after COVID-19 Hospitalization: Data from a comprehensive telerehabilitation program. Arch Phys Med Rehabil. 2021; 102(7):1308-16. [DOI:10.1016/j.apmr.2021.03.001] [PMID] [PMCID] [DOI:10.1016/j.apmr.2021.03.001]
82. Darcis G, Bouquegneau A, Maes N, Thys M, Henket M, Labye F, et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: A monocentric prospective observational cohort study. Int J Infect Dis. 2021; 109:209-16. [DOI:10.1016/j.ijid.2021.07.016] [PMID] [PMCID] [DOI:10.1016/j.ijid.2021.07.016]
83. Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021; 8:100186. [DOI:10.1016/j.lanepe.2021.100186] [PMID] [PMCID] [DOI:10.1016/j.lanepe.2021.100186]
84. Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients one year after COVID-19: A prospective cohort study. Clin Infect Dis. 2022; 74(7):1191-8. [DOI:10.1093/cid/ciab611] [PMID] [PMCID] [DOI:10.1093/cid/ciab611]
85. Miwa M, Nakajima M, Kaszynski RH, Hamada S, Ando H, Nakano T, et al. Abnormal pulmonary function and imaging studies in critical COVID-19 survivors at 100 days after the onset of symptoms. Respir Investig. 2021; 59(5):614-21. [DOI:10.1016/j.resinv.2021.05.005] [PMID] [PMCID] [DOI:10.1016/j.resinv.2021.05.005]
86. Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, Laouénan C; French COVID cohort study and investigators groups. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: Results from a large prospective cohort. Clin Microbiol Infect. 2021; 27(7):1041.e1-e4. [DOI:10.1016/j.cmi.2021.03.012] [PMID] [PMCID] [DOI:10.1016/j.cmi.2021.03.012]
87. Leth S, Gunst JD, Mathiasen V, Hansen K, Søgaard O, Østergaard L, et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. 2021; 8(4):ofab042. [DOI:10.1093/ofid/ofab042] [PMID] [PMCID] [DOI:10.1093/ofid/ofab042]
88. Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021; 11(1):13153. [DOI:10.1038/s41598-021-92045-x] [PMID] [PMCID] [DOI:10.1038/s41598-021-92045-x]
89. Varghese J, Sandmann S, Ochs K, Schrempf IM, Frömmel C, Dugas M, et al. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci Rep. 2021; 11(1):12775. [DOI:10.1038/s41598-021-91270-8] [PMID] [PMCID] [DOI:10.1038/s41598-021-91270-8]
ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA
ارسال پیام به نویسنده مسئول

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به مجله دانشگاه علوم پزشکی قم می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق
© 2025 CC BY-NC 4.0 | Qom University of Medical Sciences Journal

Designed & Developed by : Yektaweb